InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Drygin Denis, Directeur Scientifique. Insider active across 1 company, notably Regulus Therapeutics Inc.. In total, 3 reports have been recorded. Split: 3 buys · 0 sell. Total volume traded: €25k. Activity tracked since 4 February 2022. The latest transaction was disclosed on 1 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
76,686 shares@ US$0.2362.6% of flowCommon StockSEC:0001209191-22-014248:0
Ideal exit: 26 Nov 2022 (T+270)
23,314 shares@ US$0.2318.7% of flowCommon StockSEC:0001209191-22-007506:0
Ideal exit: 1 Nov 2022 (T+270)
23,314 shares@ US$0.23100.0% of flowCommon StockSEC:0001209191-22-007506
Ideal exit: 1 Nov 2022 (T+270)
3 of 3 declarations
About Drygin Denis
Denis Drygin is Chief Scientific Officer at Regulus Therapeutics Inc. He is responsible for leading research and the development of new treatments. His scientific expertise is essential for the innovation and success of the company.
